Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Neoplasms 9Breast Neoplasms 8Colonic Neoplasms 5Prostatic Neoplasms 4Lung Neoplasms 4Respiratory Aspiration 3Brain Neoplasms 3Supratentorial Neoplasms 2Rectal Neoplasms 2Pituitary Neoplasms 2Patient Satisfaction 2Emergence Delirium 2Agnosia 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Seizures 1Respiration Disorders 1Recovery 1Rare Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Postoperative Cognitive Complications 1Polyps 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endobronchial Metastases × Propofol × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡